Schonfeld Strategic Advisors LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 168 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$508,355
-35.1%
102,285
-17.8%
0.00%
-42.9%
Q4 2022$783,105
-72.5%
124,500
-52.8%
0.01%
-70.8%
Q3 2022$2,851,000
+111.2%
263,891
+122.9%
0.02%
+84.6%
Q2 2022$1,350,000
+84.4%
118,400
+47.3%
0.01%
+85.7%
Q1 2022$732,000
-29.6%
80,400
+98.5%
0.01%
-36.4%
Q3 2021$1,040,000
-61.8%
40,500
-61.2%
0.01%
-62.1%
Q2 2021$2,719,000
+910.8%
104,279
+942.8%
0.03%
+190.0%
Q4 2018$269,00010,0000.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders